Envista (NYSE:NVST) Posts Earnings Results, Beats Expectations By $0.05 EPS

Envista (NYSE:NVST) posted its earnings results on Wednesday. The company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05, FiscalAI reports. The business had revenue of $705.50 million during the quarter, compared to analyst estimates of $680.04 million. Envista had a return on equity of 7.09% and a net margin of 2.41%.The company’s quarterly revenue was up 14.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.24 EPS. Envista updated its FY 2026 guidance to 1.350-1.450 EPS.

Here are the key takeaways from Envista’s conference call:

• Envista reported a strong Q1 with core sales up 9.5% (?4% normalized excluding extra billing days and Spark deferral), adjusted EBITDA +25% and adjusted EPS +50%, and management reaffirmed full?year 2026 guidance.
• Leadership expanded shareholder returns, authorizing an incremental $300 million buyback (1.6M shares purchased in Q1) while maintaining a conservative balance sheet with net debt <1x adjusted EBITDA.
• Continued investment and execution — double?digit increases in sales & marketing and R&D, plus Envista Business System gains — drove a 100 bps gross margin uplift and 120 bps adjusted EBITDA margin improvement.
• Regional and policy risks pose near?term headwinds, notably VBP-related channel destocking in China causing double?digit implant declines there, plus geopolitical uncertainty in the Middle East and a looming Q4 billing?day timing headwind.
• Cash and cost dynamics are mixed — Q1 free cash flow was a seasonal –$16M as CapEx rose for new facilities and tariffs added about $11M of costs, but management still expects roughly 100% free cash flow conversion for 2026.

Envista Price Performance

Shares of Envista stock traded down $0.03 on Friday, hitting $24.27. The company’s stock had a trading volume of 4,873,624 shares, compared to its average volume of 2,875,691. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38. Envista has a 1 year low of $16.41 and a 1 year high of $30.42. The firm has a fifty day moving average price of $26.53 and a 200-day moving average price of $24.06. The company has a market capitalization of $3.95 billion, a price-to-earnings ratio of 59.18, a price-to-earnings-growth ratio of 1.85 and a beta of 0.92.

Key Headlines Impacting Envista

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Envista reported better-than-expected Q1 2026 results, with EPS of $0.36 versus the $0.31 consensus and revenue of $705.5 million versus $680.0 million expected, suggesting solid demand and execution. Envista (NYSE:NVST) Posts Better-Than-Expected Sales In Q1 CY2026
• Positive Sentiment: Management’s earnings transcript and presentation are likely reinforcing confidence in the turnaround and highlighting new growth drivers, which can support the stock if investors see improving fundamentals. Envista (NVST) Q1 2026 Earnings Transcript
• Positive Sentiment: Robert W. Baird raised its price target on Envista to $31 from $30 and kept an outperform rating, while JPMorgan lifted its target to $29 from $26, signaling improved analyst sentiment after the earnings beat.
• Positive Sentiment: Zacks highlighted Envista as a top long-term growth stock, which may help reinforce the market’s view that the company has attractive longer-term earnings potential. Why Envista (NVST) is a Top Growth Stock for the Long-Term
• Neutral Sentiment: Additional coverage on the Q1 earnings snapshot and key metrics is mostly informational, but it keeps the company in focus as investors assess whether the earnings beat is sustainable. Envista: Q1 Earnings Snapshot
• Neutral Sentiment: The stock still faces some caution because JPMorgan’s rating remained neutral despite the higher target, indicating analysts see upside but not a clear near-term rerating.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Envista from a “buy” rating to a “strong-buy” rating in a report on Monday, January 26th. William Blair raised shares of Envista from a “hold” rating to an “outperform” rating in a report on Friday, February 6th. Leerink Partners set a $35.00 target price on shares of Envista and gave the company an “outperform” rating in a report on Friday, February 6th. Barclays increased their price target on shares of Envista from $24.00 to $34.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 11th. Finally, Citigroup initiated coverage on shares of Envista in a research note on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price target on the stock. Six research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $28.83.

Insider Transactions at Envista

In related news, SVP Mischa Reis sold 9,675 shares of the business’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total value of $290,250.00. Following the completion of the sale, the senior vice president owned 32,382 shares of the company’s stock, valued at approximately $971,460. The trade was a 23.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.99% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Invesco Ltd. grew its holdings in shares of Envista by 333.9% during the fourth quarter. Invesco Ltd. now owns 1,546,528 shares of the company’s stock worth $33,575,000 after buying an additional 1,190,088 shares during the last quarter. Corient Private Wealth LLC lifted its position in Envista by 384.2% in the fourth quarter. Corient Private Wealth LLC now owns 108,643 shares of the company’s stock valued at $2,359,000 after purchasing an additional 86,204 shares during the period. Mercer Global Advisors Inc. ADV lifted its position in Envista by 241.4% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 71,430 shares of the company’s stock valued at $1,551,000 after purchasing an additional 50,509 shares during the period. First Citizens Bank & Trust Co. acquired a new stake in Envista in the fourth quarter valued at about $1,242,000. Finally, EP Wealth Advisors LLC acquired a new stake in Envista in the fourth quarter valued at about $301,000.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.